Article

The future promise of advanced therapies in ophthalmology

Six years after the first approved gene therapy in ophthalmology, the field is seeing a flurry of activity in innovative cell and gene therapy (CGT) studies addressing high unmet needs. Here’s what could be in store for the future.

Louis Cicchini
Director, Scientific Affairs, Cell & Gene Therapy at Cencora

Fill out the form below to read more

Pardot Form

Related resources

Article

From AI to regulatory layering and convergence: Key takeaways from RAPS Euro Convergence 2026

Learn more

Article

How U.S. pricing reform is reshaping global market dynamics

Learn more

Guide

Cell and gene therapy playbook for payer engagement: Translating payer expectations into actionable market access strategies

Learn more

Connect with our cell and gene experts

Schedule some time with our cell and gene experts today. We look forward to hearing from you.